These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 23252824)
1. Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice. Kesby JP; Hubbard DT; Markou A; Semenova S Addict Biol; 2014 Jul; 19(4):593-605. PubMed ID: 23252824 [TBL] [Abstract][Full Text] [Related]
2. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice. Kesby JP; Markou A; Semenova S; Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577 [TBL] [Abstract][Full Text] [Related]
3. The motivational valence of methamphetamine relates inversely to subsequent methamphetamine self-administration in female C57BL/6J mice. Shab G; Fultz EK; Page A; Coelho MA; Brewin LW; Stailey N; Brown CN; Bryant CD; Kippin TE; Szumlinski KK Behav Brain Res; 2021 Feb; 398():112959. PubMed ID: 33053382 [TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Henry BL; Geyer MA; Buell M; Perry W; Young JW; Minassian A; Behav Brain Res; 2013 Jan; 236(1):210-220. PubMed ID: 22960458 [TBL] [Abstract][Full Text] [Related]
5. Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120. Roberts AJ; Maung R; Sejbuk NE; Ake C; Kaul M J Neurosci Methods; 2010 Feb; 186(2):222-5. PubMed ID: 19917310 [TBL] [Abstract][Full Text] [Related]
6. Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice. Wang ZY; Guo LK; Han X; Song R; Dong GM; Ma CM; Wu N; Li J Behav Brain Res; 2021 Feb; 399():112971. PubMed ID: 33075396 [TBL] [Abstract][Full Text] [Related]
7. Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Wheeler JM; Reed C; Burkhart-Kasch S; Li N; Cunningham CL; Janowsky A; Franken FH; Wiren KM; Hashimoto JG; Scibelli AC; Phillips TJ Genes Brain Behav; 2009 Nov; 8(8):758-71. PubMed ID: 19689456 [TBL] [Abstract][Full Text] [Related]
8. Persistent palatable food preference in rats with a history of limited and extended access to methamphetamine self-administration. Caprioli D; Zeric T; Thorndike EB; Venniro M Addict Biol; 2015 Sep; 20(5):913-26. PubMed ID: 25582886 [TBL] [Abstract][Full Text] [Related]
9. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses. Sakoori K; Murphy NP Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627 [TBL] [Abstract][Full Text] [Related]
10. Cdh13 and AdipoQ gene knockout alter instrumental and Pavlovian drug conditioning. King CP; Militello L; Hart A; St Pierre CL; Leung E; Versaggi CL; Roberson N; Catlin J; Palmer AA; Richards JB; Meyer PJ Genes Brain Behav; 2017 Sep; 16(7):686-698. PubMed ID: 28387990 [TBL] [Abstract][Full Text] [Related]
11. Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine. Gubner NR; Reed C; McKinnon CS; Phillips TJ Behav Brain Res; 2013 Nov; 256():420-7. PubMed ID: 23994231 [TBL] [Abstract][Full Text] [Related]
12. Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Hoefer MM; Sanchez AB; Maung R; de Rozieres CM; Catalan IC; Dowling CC; Thaney VE; PiƱa-Crespo J; Zhang D; Roberts AJ; Kaul M Exp Neurol; 2015 Jan; 263():221-34. PubMed ID: 25246228 [TBL] [Abstract][Full Text] [Related]
13. Agmatine attenuates methamphetamine-induced conditioned place preference in rats. Thorn DA; Winter JC; Li JX Eur J Pharmacol; 2012 Apr; 680(1-3):69-72. PubMed ID: 22329899 [TBL] [Abstract][Full Text] [Related]
14. Region-specific changes in markers of neuroplasticity revealed in HIV-1 transgenic rats by low-dose methamphetamine. Ohene-Nyako M; Persons AL; Napier TC Brain Struct Funct; 2018 Sep; 223(7):3503-3513. PubMed ID: 29931627 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice. Mori T; Uzawa N; Masukawa D; Hirayama S; Iwase Y; Hokazono M; Udagawa Y; Suzuki T Behav Brain Res; 2021 Jan; 396():112802. PubMed ID: 32653557 [TBL] [Abstract][Full Text] [Related]
16. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior. Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice. Kesby JP; Heaton RK; Young JW; Umlauf A; Woods SP; Letendre SL; Markou A; Grant I; Semenova S Neuropsychopharmacology; 2015 Jul; 40(8):1899-909. PubMed ID: 25652249 [TBL] [Abstract][Full Text] [Related]
18. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Nakagawa T; Fujio M; Ozawa T; Minami M; Satoh M Behav Brain Res; 2005 Jan; 156(2):233-9. PubMed ID: 15582109 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats. Zakharova E; Leoni G; Kichko I; Izenwasser S Behav Brain Res; 2009 Mar; 198(1):45-50. PubMed ID: 18996417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]